CPRX•benzinga•
Catalyst Pharmaceuticals Settles Patent Litigation Case With Teva Pharmaceutical
Summary
Catalyst Pharmaceuticals settles patent litigation with Teva, delaying generic Firdapse launch until 2035. Legal actions against other defendants remain ongoing.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 9, 2025 by benzinga